CLINICAL_TRIALS
research
· 2026-03-03
Clinical Trial Update: Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI) [Phase 1]
Summary
A Phase 1 clinical trial evaluating intravenous DNase I for the treatment of sepsis is currently recruiting (IDEALSepsisI).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: McMaster University | Conditions: Sepsis, Critical Illness | Phase 1 | Status: RECRUITING